MW
Marcum Wealth Portfolio holdings
AUM
$1.16B
This Quarter Return
+7.68%
1 Year Return
+6.7%
3 Year Return
+19.95%
5 Year Return
+103.74%
10 Year Return
–
AUM
$986M
AUM Growth
+$986M
(+4.9%)
Cap. Flow
-$17.1M
Cap. Flow
% of AUM
-1.73%
Top 10 Holdings %
Top 10 Hldgs %
59.58%
Holding
433
New
34
Increased
149
Reduced
157
Closed
23
Top Buys
| 1 |
Innovator US Equity Buffer ETF January
BJAN
|
$6.15M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
$4.79M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
$2.94M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
$2.6M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$2.55M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
$19.1M |
| 2 |
Schwab US Large- Cap ETF
SCHX
|
$9.67M |
| 3 |
Innovator US Equity Buffer ETF July
BJUL
|
$4.96M |
| 4 |
Innovator US Small Cap Power Buffer ETF July
KJUL
|
$1.86M |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
$1.75M |
Sector Composition
| 1 | Technology | 6.53% |
| 2 | Financials | 4.47% |
| 3 | Industrials | 3.71% |
| 4 | Healthcare | 2.44% |
| 5 | Consumer Discretionary | 2.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Corcept Therapeutics
CORT
$7.52B
| $253K | 0.03% |
10,029
| – | – |
|
302
KLA
KLAC
$112B
| $252K | 0.03% |
+361
| New | +$252K |
|
303
Sanofi
SNY
$121B
| $252K | 0.03% |
+5,176
| New | +$252K |
|
304
Vanguard Russell 1000 ETF
VONE
$6.6B
| $250K | 0.03% |
1,049
| – | – |
|
305
Southern Company
SO
$101B
| $246K | 0.02% |
3,427
-1,167
| -25% | -$83.7K |
|
306
Under Armour
UAA
$2.16B
| $246K | 0.02% |
33,298
+12,987
| +64% | +$95.8K |
|
307
Crown Castle
CCI
$42.7B
| $243K | 0.02% |
2,296
+73
| +3% | +$7.73K |
|
|
PXD
308
DELISTED
Pioneer Natural Resource Co.
PXD
| $243K | 0.02% |
925
+27
| +3% | +$7.09K |
|
309
Cintas
CTAS
$82.8B
| $243K | 0.02% |
353
-2
| -0.6% | -$1.37K |
|
310
SPDR S&P Semiconductor ETF
XSD
$1.39B
| $241K | 0.02% |
1,040
| – | – |
|
311
Biogen
BIIB
$20.5B
| $237K | 0.02% |
1,099
-96
| -8% | -$20.7K |
|
312
Olin
OLN
$2.7B
| $233K | 0.02% |
3,960
-25
| -0.6% | -$1.47K |
|
313
Leidos
LDOS
$23.2B
| $232K | 0.02% |
+1,772
| New | +$232K |
|
314
Ameriprise Financial
AMP
$48.3B
| $231K | 0.02% |
526
-6
| -1% | -$2.63K |
|
315
iShares ESG Advanced MSCI EAFE ETF
DMXF
$814M
| $230K | 0.02% |
3,380
+3
| +0.1% | +$204 |
|
316
Markel Group
MKL
$24.6B
| $230K | 0.02% |
151
-2
| -1% | -$3.04K |
|
317
Xylem
XYL
$34.2B
| $225K | 0.02% |
+1,744
| New | +$225K |
|
318
Zoetis
ZTS
$67.8B
| $225K | 0.02% |
1,331
+18
| +1% | +$3.05K |
|
319
iShares Core High Dividend ETF
HDV
$11.7B
| $225K | 0.02% |
2,043
-474
| -19% | -$52.2K |
|
320
Workday
WDAY
$61.1B
| $224K | 0.02% |
823
+73
| +10% | +$19.9K |
|
321
Vulcan Materials
VMC
$38.6B
| $224K | 0.02% |
819
-92
| -10% | -$25.1K |
|
322
Realty Income
O
$52.8B
| $223K | 0.02% |
+4,124
| New | +$223K |
|
323
Labcorp
LH
$22.8B
| $222K | 0.02% |
1,017
+13
| +1% | +$2.84K |
|
324
O'Reilly Automotive
ORLY
$87.6B
| $221K | 0.02% |
+196
| New | +$221K |
|
325
iShares US Medical Devices ETF
IHI
$4.3B
| $219K | 0.02% |
3,738
-241
| -6% | -$14.1K |
|